Cefaclor

30 October 2009

Products Affected - Description

Cefaclor Suspension 125 mg/5 mL, Ranbaxy
75 mL bottle (NDC 63304-0954-01)
150 mL bottle (NDC 63304-0954-02)

Cefaclor Suspension 250 mg/ 5 mL, Ranbaxy
75 mL bottle (NDC 63304-0956-01)
150 mL bottle (NDC 63304-0956-02)

Cefaclor Suspension 375 mg/ 5 mL, Ranbaxy
50 mL bottle (NDC 63304-0957-03)
100 mL bottle (NDC 63304-0957-04)

Reason for the Shortage

• Cefaclor suspension is one of 30 generic products from Ranbaxy that has an FDA import ban.
• There are no other manufacturers of cefaclor suspension.
  

Estimated Resupply Dates

Ranbaxy has all cefaclor suspensions on back order and the company cannot estimate a release date.

Related Shortages

• Aztreonam Injection
• Carbenicillin Indanyl Capsules— No Longer Available
• Cefazolin Injection— Resolved
• Cefepime Injection— Resolved
• Cefotetan Disodium— Resolved
• Cefotetan Injection— Resolved
• Cefoxitin Injection— Resolved
• Ceftizoxime Injection— Resolved
• Cefuroxime Injection— Resolved
• Ciprofloxacin Immediate-Release Tablets
• Doxycycline Hyclate Injection
• Erythromycin Lactobionate Injection
• Erythromycin Ophthalmic Ointment
• Imipenem and Cilastatin Injection— Resolved
• Kanamycin— Resolved
• Kanamycin Sulfate Injection
• Loracarbef Oral Tablets and Suspension— No Longer Available
• Minocycline Injection— No Longer Available
• Nafcillin Injection— Resolved
• Oxacillin Injection— Resolved
• Penicillin G Benzathine Injection— Resolved
• Penicillin G Procaine Suspension for Injection— Resolved
• Piperacillin and Tazobactam Injection— Resolved
• Polymyxin B Injection— Resolved
• Ticarcillin and Clavulanate Injection— Resolved
• Tigecycline Injection— Resolved
• Tobramycin Powder for Injection
• Vancomycin Hydrochloride Injection

Updated

October 30, 2009; September 25, 2009; August 20, 2009, University of Utah, Drug Information Service Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins